What is the CVKD stock price prediction for next 2 weeks?

According to our price prediction algorithm,Cadrenal Therapeutics, Inc. Common Stock (CVKD) price will be around $6.59 in the next 2 weeks. This means it will decrease by -1.1454272863568153 from the last closing price. This prediction may vary from other time period filters for CVKD stock.

What can be the highest Possible price of CVKD stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, CVKD can achieve the highest price of $7.09 which is 6.238208698737824 higher than last closing price. This prediction may vary from other time period filters for CVKD stock.

What can be the lowest Possible price of CVKD stock in next 2 weeks?

As per the forecast and algorithmic analysis, CVKD stock price can be as low as $6.11 which is -8.34380689543759 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for CVKD stock.

Will CVKD stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that CVKD stock will lose-1.1454272863568153 in the next 2 weeks. This prediction may vary from other time period filters for CVKD stock.

What is CVKD stock last closing price?

Last closing price of CVKD stock was $6.67.

What is CVKD stock price prediction?

CVKD stock price prediction means predicting the future closing prices of CVKD stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CVKD stock in a certain time period.

How we predict CVKD stock future prices?

If you are searching for CVKD stock forecast, analysis or price prediction, then you might be wondering what Cadrenal Therapeutics, Inc. Common Stock (CVKD) will do in the future. Our CVKD price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CVKD price prediction will likely answer most of your questions.

How frequent we update CVKD stock predictions?

We are updating the forecasts for the CVKD stock on daily basis.

Is using ML forecasting for CVKD stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for CVKD stock same for all the time periods?

No, the prediction for CVKD stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Cadrenal Therapeutics, Inc. Common Stock Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$6.6727.78%Since 2 Weeks

Predicted Price$6.59-1.15%For 2 Weeks

Upper Predicted Price$7.096.24%For 2 Weeks

Lower Predicted Price$6.11-8.34%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of CVKD will decline by -1.15% over the next 2 Weeks and hit $6.59 by Thursday, May 14, 2026. In that time frame, CVKD's share price is expected to range between $6.11 and $7.09.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 14, 2026	6.11	6.59	7.09
May 13, 2026	6.07	6.55	6.99
May 12, 2026	6.00	6.46	6.93
May 11, 2026	5.96	6.41	6.87
May 8, 2026	5.80	6.22	6.68
May 7, 2026	5.96	6.37	6.82
May 6, 2026	5.91	6.33	6.75
May 5, 2026	5.82	6.24	6.65
May 4, 2026	5.79	6.19	6.61
May 1, 2026	5.62	6.00	6.41

CVKD shares fell -4.80% in Friday, May 1, 2026's trading session, dropping from a previous close of $6.67 to move at $6.35. The stock demonstrated notable intraday movement (see CVKD's key stats for a full breakdown), fluctuating between $6.16 and $7.18, a +16.56% trading range. While recent weeks have seen some volatility, CVKD has managed to secure a +30.93% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 111.79K shares changing hands, 57.18K more than the previous session. This amounted to $709.89K in total market activity.

Will CVKD Continue Its Upward Trend?

According to analyst ratings and projections for CVKD, Cadrenal Therapeutics, Inc. Common Stock shares are anticipated to increase by +10.39%, potentially reaching $7.09 per share by May 14, 2026. Short-term technical indicators currently suggest a neutral sentiment for CVKD. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the CVKD stock forecast, now is a good time to buy CVKD stock because its current trading price is -3.69% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CVKD covering social and institutional perspectives.

CVKD Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CVKD's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 54.32% to 63.58%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 47.74%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.67%, maintains a neutral outlook for the long term. Insights into CVKD's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Cadrenal Therapeutics Common Stock Short-Term Forecasts

CVKD Forecast For Next 5 Days

Our algorithm anticipates Cadrenal Therapeutics Common Stock (CVKD) stock could hit $4.96 by May 08, 2026. This represents a -21.87% fall from today's price, following a -13.60% change over the past five days.

CVKD Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $4.27, which would mean a -32.76% decrease from the current price of $6.35. Projections for this period range from a high of $6.04 to a low of $2.49.

CVKD Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Cadrenal Therapeutics Common Stock's price over the next three months point to a rise. CVKD stock is expected to peak at $12.53 on Jun 10, 2026 before potentially dipping to $6.22 on Jul 31, 2026. On average, CVKD is likely to trade around $10.29 in the coming 90 days.

Cadrenal Therapeutics Common Stock Stock Forecast 2025

Based on our predictive models, Cadrenal Therapeutics Common Stock (CVKD) is expected to trade between $0.00 and $12.53 throughout 2026. This would result in an average price of $8.06, potentially offering investors a +26.93% return from current levels.

Cadrenal Therapeutics, Inc. Common Stock Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Cadrenal Therapeutics, Inc. Common Stock (CVKD) is positioned to show a strong performance in May 2026. The price is predicted to move between $9.97 and $11.98, settling at an average of $10.97. This could translate to a +72.76% gain.

June 2026

Based on current market signals, Cadrenal Therapeutics, Inc. Common Stock is projected to trend june 2026. We forecast a trading range from $8.77 to $12.53, with a likely average price of $11.19. Investors could expect a potential return of +76.22%.

July 2026

Our predictive algorithms indicate Cadrenal Therapeutics, Inc. Common Stock stock may see a shift in July 2026. The expected range spans $6.22–$10.29, with an average target of $8.84. This represents a positive outlook and a possible gain of +39.21%.

August 2026

Analyzing established trends, Cadrenal Therapeutics, Inc. Common Stock looks set to move in August 2026. Projections place the stock between $5.50 and $8.29, averaging around $7.46. This suggests a +17.48% gain from current levels.

September 2026

Market indicators suggest Cadrenal Therapeutics, Inc. Common Stock could experience notable changes during September 2026. Prices could fluctuate within $3.78 to $8.17, with a midpoint forecast of $7.44. The stock might deliver a +17.17% gain.

October 2026

Forecasting for October 2026, models estimate that Cadrenal Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $1.65 and $6.94, averaging $7.48. This signals a positive trajectory with potential returns around +17.80%.

November 2026

According to our latest forecast models, Cadrenal Therapeutics, Inc. Common Stock (CVKD) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.00 and $5.60, settling at an average of $6.65. This could translate to a +4.72% gain.

December 2026

Based on current market signals, Cadrenal Therapeutics, Inc. Common Stock is projected to trend december 2026. We forecast a trading range from $0.00 to $2.79, with a likely average price of $4.75. Investors could expect a potential return of -25.20%.

January 2027

Our predictive algorithms indicate Cadrenal Therapeutics, Inc. Common Stock stock may see a shift in January 2027. The expected range spans $0.00–$1.27, with an average target of $4.72. This represents a cautious outlook and a possible loss of -25.67%.

February 2027

Analyzing established trends, Cadrenal Therapeutics, Inc. Common Stock looks set to move in February 2027. Projections place the stock between $0.00 and $0.00, averaging around $3.90. This suggests a -38.58% loss from current levels.

March 2027

Market indicators suggest Cadrenal Therapeutics, Inc. Common Stock could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $0.00, with a midpoint forecast of $3.13. The stock might deliver a -50.71% loss.

April 2027

Forecasting for April 2027, models estimate that Cadrenal Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $2.63. This signals a cautious trajectory with potential returns around -58.58%.

CVKD's history of dividends and stock splits also plays a role in long-term investor confidence.